STAT3 and prostate carcinoma: A previous recent study demonstraets that STAT3 functions as a positive transcription factor to induce the expression of proteasomal subunits and that the inhibition of STAT3 is closely associated with decreases in the expression levels of proteasome subunits and proteasome-mediated protease activity in prostate cancer [6].